New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Apollo Investment Corp (NASDAQ:AINV), Peregrine Pharmaceuticals (NASDAQ:PPHM), ReneSola Ltd. (ADR) (NYSE:SOL), Pain Therapeutics, Inc (NASDAQ:PTIE)
Apollo Investment Corp (NASDAQ:AINV) showed a volume of 2.97 million shares by the end of last trade whereas the average volume of the stock remained 1.42 million shares. The stock opened the session at $8.69 but then moved to $8.92. At that price, the stock showed a positive performance of 3.00%. Apollo Investment Corporation (Apollo Investment) is a closed-end, non-diversified management investment company that has elected to be treated as a business development company. Its investment objective is to generate current income and capital appreciation. It invests primarily in various forms of debt investments, including senior secured loans, subordinated and mezzanine investments and/or equity in private middle market companies.
Will AINV Continue To Move Higher? Find Out Here
Peregrine Pharmaceuticals (NASDAQ:PPHM) opened the session at $1.76 and closed the session at $1.72. Traded with volume of 2.93 million shares in the prior session and the average volume of the stock remained 2.96 million shares. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies. Bavituximab is the Company's therapeutic PS-targeting antibody,
Is PPHM a Solid Investment at These Levels? Read This Report For Details
ReneSola Ltd. (ADR) (NYSE:SOL) opened the session at $4.08 and closed the session at $4.00. The stock showed a negative performance of -0.74% in previous trading session. Traded with volume of 2.91 million shares in the prior session and the average volume of the stock remained 4.22 million shares. The beta of the stock remained 3.17. ReneSola Ltd (ReneSola), incorporated on March 17, 2006, is a global manufacturer of solar wafers and producer of solar power products based in the People's Republic of China. ReneSola possess a global network of suppliers and customers that includes some of the global manufacturers of solar cells and modules.
Why Should Investors Buy SOL After the Recent Fall? Just Go Here and Find Out
Pain Therapeutics, Inc (NASDAQ:PTIE) the stock decreased -14.26% and finished the session at $4.39. Traded with volume of 2.88 million shares in the prior session and the average volume of the stock remained 256,244 shares. The beta of the stock remained 0.77. Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. It has collaboration agreement with King Pharmaceuticals, Inc. (King) develops and commercializes REMOXY and other opioid painkillers.
Will PTIE Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)